Ipro in PCI - Glycemic Variability Assessed by Continuous Glucose Monitoring and its Correlation with Renal and Myocardial Damage after Coronary Stenting
Project objectivesTo evaluate the diagnostic and prognostic efficacy of continuous glucose monitoring using the Ipro device in diabetic and non-diabetic patients undergoing coronary stenting. Specifically, to correlate Holter glucose indicators with pre- and post-procedural changes in creatinine and troponin levels and platelet reactivity indices. |
Start and end date |
|
March 2013 - ongoing |
Project Manager |
|
Dr. Annunziata Nusca - Principal Investigator |
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
